Dublin, Sept. 25, 2025 (GLOBE NEWSWIRE) — The “Health and Medical Reinsurance Market Report 2025” has been added to ResearchAndMarkets.com’s offering.
The health and medical reinsurance market has experienced significant growth, expanding from $70.53 billion in 2024 to an anticipated $76.32 billion in 2025, at a CAGR of 8.2%. This growth is attributed to the rising prevalence of chronic diseases, elevated healthcare expenditures, and increasing demand for risk-sharing solutions along with stricter regulatory mandates.
Further, the market is forecasted to reach $103.25 billion by 2029, growing at a CAGR of 7.8% due to the adoption of digital health platforms, demand for customized reinsurance models, and a heightened focus on financial risk mitigation. Innovations such as AI-powered risk assessment tools, improved data analytics, and advancements in health claim management systems are key trends for this period.
The rising incidence of chronic diseases significantly contributes to market growth. Conditions like heart disease and diabetes often require long-term treatment, and health reinsurance plays a vital role in managing these financial burdens by covering high-risk claims. For instance, a report from the UK’s National Health Service indicated a significant rise in non-diabetic hyperglycemia diagnoses between 2022 and 2023.
Market players are keen on strategic expansions to enhance regional presence. In January 2025, Aon plc launched a life and health reinsurance practice in India, catering to the country’s burgeoning insurance market. Meanwhile, Arthur J. Gallagher & Co. strengthened its Canadian market presence with its acquisition of MGB Re, a broker specializing in health reinsurance solutions.
Key industry players include Berkshire Hathaway Reinsurance Group, Allianz Reinsurance, Munich Reinsurance Company, and many others. North America dominated the market in 2024, with Asia-Pacific projected as the fastest-growing region. Countries covered in this market include Australia, China, India, Japan, the UK, and the USA among others.
Report Scope
This report delves into the largest and fastest-growing markets for health and medical reinsurance and their correlation with the economy, demography, and similar sectors. It examines the forces likely to impact the market, including technological innovations, regulatory changes, and evolving consumer demands. Additionally, the report addresses market characteristics, size, growth potential, segmentation, regional and country analyses, competitive landscapes, market shares, as well as trends and strategies. It traces historical growth while forecasting regional and market expansion.
- Markets Covered: Includes Life Reinsurance Products, Health Reinsurance Products, Disability Reinsurance Products, and Long Term Care Reinsurance Products.
- Type of Coverage: Comprehensive Reinsurance, Excess of Loss Reinsurance, Quota Share Reinsurance, Stop Loss Reinsurance.
- Risk Type: Mortality Risk, Morbidity Risk, Operational Risk, Regulatory Risk.
- Healthcare Sector: Private Healthcare Providers, Public Healthcare Providers, Non-Profit Healthcare Organizations, Managed Care Organizations.
- End User: Insurance Companies, Self-Insured Employers, Government, Others.
Subsegments:
- Life Reinsurance Products include Term Life Reinsurance, Whole Life Reinsurance, among others.
- Health Reinsurance Products cover Individual Health Reinsurance, Group Health Reinsurance, and more.
- Disability Reinsurance Products feature Short-Term and Long-Term Disability Reinsurance options.
- Long Term Care Reinsurance Products encapsulate Facility-Based, Home-Based, and Comprehensive LTC Reinsurance.
Leading Companies: The report includes data on major industry players such as Berkshire Hathaway Reinsurance Group, Allianz Reinsurance, Munich Reinsurance Company, MS&AD Insurance Group Holdings Inc., and others.
Geographical Coverage: Examines markets in Australia, Brazil, China, France, Germany, India, and more, including regional insights from Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
Data Insights: Offers ratios of market size and growth compared to related markets, GDP proportions, expenditure per capita, and segmented historic and forecast data.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 250 |
| Forecast Period | 2025-2029 |
| Estimated Market Value (USD) in 2025 | $76.32 Billion |
| Forecasted Market Value (USD) by 2029 | $103.25 Billion |
| Compound Annual Growth Rate | 7.8% |
| Regions Covered | Global |
The companies featured in this Health and Medical Reinsurance market report include:
- Berkshire Hathaway Reinsurance Group
- Allianz Reinsurance
- Munich Reinsurance Company
- MS&AD Insurance Group Holdings Inc.
- Swiss Reinsurance Company Ltd.
- Hannover Ruck SE
- Mapfre Re Compania de Reaseguros S.A.
- SCOR SE
- RGA Reinsurance Company
- China Reinsurance Group Corporation
- QBE Reinsurance
- Everest Re Group Ltd.
- Validus Reinsurance Ltd.
- AXA XL Reinsurance
- PartnerRe Ltd.
- AXIS Capital Holdings Limited
- Korean Reinsurance Company
- General Reinsurance Corporation
- Transatlantic Reinsurance Company
- Odyssey Re Holdings Corp.
For more information about this report visit https://www.researchandmarkets.com/r/xjxgqe
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Health and Medical Reinsurance Market
